164 related articles for article (PubMed ID: 3278821)
1. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
[TBL] [Abstract][Full Text] [Related]
2. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
Collart F; Staroukine M; Verniory A
Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Manhem P; Hökfelt B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
[No Abstract] [Full Text] [Related]
4. The effect of chronic guanfacine administration on high plasma vasopressin levels in essential hypertension.
Berkman K; Tözün N; Taga Y; Dedeoğlu A; Onat F; Bekiroğlu N
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):67-71. PubMed ID: 2407671
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of long-term treatment of essential hypertension with guanfacine.
Higuchi M; Overlack A; Stumpe KO
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
Rosenthal JH
Am J Cardiol; 1986 Mar; 57(9):22E-26E. PubMed ID: 3513526
[TBL] [Abstract][Full Text] [Related]
7. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
8. Effects of single and multiple doses of guanfacine in essential hypertension.
Zamboulis C; Reid JL
Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
[TBL] [Abstract][Full Text] [Related]
9. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
10. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
11. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
[TBL] [Abstract][Full Text] [Related]
12. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
[TBL] [Abstract][Full Text] [Related]
13. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
14. Guanfacine: effects of long-term treatment and withdrawal.
Reid JL; Zamboulis C; Hamilton CA
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effects and plasma levels of guanfacine in man.
Safar ME; Loria Y; Weiss YA; Boutier JR
J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
[TBL] [Abstract][Full Text] [Related]
16. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
17. Effects of clonidine and guanfacine in essential hypertension.
Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
Roeckel A; Heidland A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
20. Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Am J Cardiol; 1986 Mar; 57(9):27E-31E. PubMed ID: 3513527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
